Joe Kuijper

Joe Kuijper has a diverse work experience spanning over several decades. Joe started their career as a Research Technician at Oncogen Inc in 1984 and worked there until 1986. Joe then joined ZymoGenetics Inc in 1986 as a Senior Scientist, where they gained experience in expression cloning, project management, ligand-receptor deorphanization, antibody library design/construction, protein engineering molecular biology, cytokine biology, and neuroendocrine satiety obesity. Joe worked at ZymoGenetics Inc until 2009.

In 2009, Joe joined Novo Nordisk as a Senior Scientist, where they served in various roles. First, they worked as a Senior Scientist in Diabetic Complications from December 2014 to November 2015. Later, they became Senior Scientist in Molecular Immunology from January 2009 to November 2014. In this role, they led a team responsible for providing molecular biology and reporter assay support to a research site and co-led the discovery platform for deorphanization of immuno receptors and ligands. Joe also served as a site lead for the TREM1 project team and contributed to a discovery platform utilizing proteins and RNAi in a complex primary cell immunoassay.

Lastly, Joe joined Alpine Immune Sciences in 2016 as a Principal Scientist in Protein Engineering. Their responsibilities included utilizing invitro evolution and rational design techniques to engineer Ig superfamily therapeutics with novel properties targeting the immune synapse. Joe expressed pride in being part of a passionate and experienced team that engaged in creative drug discovery work.

Joe Kuijper obtained a Bachelor of Science (BS) degree in Cell/Cellular and Molecular Biology from the University of Washington. No further details about their education history are available.